Intercure Ltd (NASDAQ: INCR) has a higher price-to-earnings ratio of 27.55x compared to its average ratio. INCR has 36-month beta value of 0.95. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 2 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for INCR is 27.37M, and currently, short sellers hold a 0.21% ratio of that float. The average trading volume of INCR on May 07, 2024 was 75.42K shares.
INCR) stock’s latest price update
Intercure Ltd (NASDAQ: INCR) has experienced a rise in its stock price by 16.03 compared to its previous closing price of 3.12. However, the company has seen a gain of 38.17% in its stock price over the last five trading days. Seeking Alpha reported 2024-04-22 that InterCure Ltd. has faced challenges due to the conflict with Hamas, including not having access to a prime facility in Israel, but is expected to recover. The cannabis market in Israel is still limited to medical use, with expansion to medical cannabis patient access to grow the market in 2024. InterCure stock is cheap at only about 1x sales, with catalysts for growth in 2024 and beyond.
INCR’s Market Performance
INCR’s stock has risen by 38.17% in the past week, with a monthly rise of 42.24% and a quarterly rise of 187.30%. The volatility ratio for the week is 9.31% while the volatility levels for the last 30 days are 5.29% for Intercure Ltd The simple moving average for the past 20 days is 37.62% for INCR’s stock, with a 121.31% simple moving average for the past 200 days.
Analysts’ Opinion of INCR
Many brokerage firms have already submitted their reports for INCR stocks, with Canaccord Genuity repeating the rating for INCR by listing it as a “Buy.” The predicted price for INCR in the upcoming period, according to Canaccord Genuity is $13 based on the research report published on May 18, 2022 of the previous year 2022.
INCR Trading at 54.12% from the 50-Day Moving Average
After a stumble in the market that brought INCR to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 14.92% of gains for the given period.
Volatility was left at 5.29%, however, over the last 30 days, the volatility rate increased by 9.31%, as shares surge +34.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +91.53% upper at present.
During the last 5 trading sessions, INCR rose by +38.17%, which changed the moving average for the period of 200-days by +119.39% in comparison to the 20-day moving average, which settled at $2.68. In addition, Intercure Ltd saw 180.66% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for INCR
Current profitability levels for the company are sitting at:
- -0.12 for the present operating margin
- 0.29 for the gross margin
The net margin for Intercure Ltd stands at -0.17. The total capital return value is set at -0.07. Equity return is now at value 4.37, with 2.64 for asset returns.
Based on Intercure Ltd (INCR), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at -0.27. The debt to equity ratio resting at 0.42. The interest coverage ratio of the stock is -3.45.
Currently, EBITDA for the company is -27.74 million with net debt to EBITDA at -2.97. When we switch over and look at the enterprise to sales, we see a ratio of 1.98. The receivables turnover for the company is 5.89for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.90.
Conclusion
To put it simply, Intercure Ltd (INCR) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
